2026-06-25
minor
Study Status v8
Completion pushed: 2026-07-31 → 2027-03-31
2026-02-08
minor
Study Status, Study Design, Outcome Measures, Participant Flow, Outcome Measures (Results), Adverse Events v7
Results first postednot stated→2026-02-27
Enrollment target30→17
Primary endpoints1 entry, revised
Change From Baseline in Investigator's Global Assessment (IGA) Score
2025-12-24
minor
Study Status, Oversight, Study Design, Outcome Measures, IPDSharing, Document Section, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, More Information v6
Completion date2025-07-31→2026-07-31
Enrollment target9→30
Secondary endpoints7 entries, revised
Change in Eczema Area and Severity Index (EASI) scoreScore
Change in Numerical Rating Scale (NRS) itchItch
Change in SLEEPY-Q (Sleep Questionnaire) scoreScore
Primary endpoints1 entry, revised
Change in Investigator's Global Assessment (IGA) scoreScore
2025-02-10
notable
Recruiting→Active, Not Recruiting Study Status, Oversight, Study Design, Contacts/Locations, IPDSharing v5
Trial statusRecruiting→Active, Not Recruiting
Primary completion dateestimated 2023-12→confirmed 2024-12-31
Completion date2023-12→2025-07-31
Enrollment targetestimated 30→confirmed 9
Study sitesdetails revised at 1 of 1 site
2023-10-29
minor
Study Status, Study Description, Study Design, Eligibility v4
Primary completion date2023-05→2023-12
Completion date2023-05→2023-12
Enrollment target20→30
Eligibility criteria+140 characters
[...] ening and baseline visits
Documented recent history (within 618 months of patch testing) of inadequate response to treatmen [...] to participate in all study visits and administer dupilumab
Resident outside of Massachusetts, Connecticut, Rhode Island, New Hampshire, Maine or Vermont state.
Unable to use Zoom videoconferencing.
Study description+1 characters
The investigators will recruit 2030 patients with allergic contact dermatitis who have not improved with allergen avoidance up to 618 months after patch testing, but where allergic contact derm [...]
Show 3 earlier versions
2021-10-12
minor
Study Status, Sponsor/Collaborators v3
Primary completion date2021-12→2023-05
Completion date2021-12→2023-05
2020-03-16
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2021-09→2021-12
Completion date2021-09→2021-12
Start dateestimated 2019-09→confirmed 2019-12-18
Study sites0→1
2019-07-10
minor
Study Status v1
Primary completion date2021-05→2021-09
Completion date2021-05→2021-09
Start date2019-05→2019-09
2019-05-01
minor
Original filing